The Bumpy Road To Approving New Alzheimer's Drugs

After a controversial Alzheimer’s medication was discontinued, a new anti-amyloid drug receives extra scrutiny from the FDA.

Related Keywords

United States ,Eli Lilly ,Jason Karlawish ,Arielle Duhaime Ross ,Human Services ,University Of Pennsylvania Perelman School Medicine ,Department Of Health ,Penn Memory Center ,Drug Administration ,Silver Spring ,Oak Campus ,United States Food ,Perelman School ,Penn Memory ,